Can a vacuum device safely suck out dangerous heart clots? a global registry investigates

NCT ID NCT07769320

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This study is a large international registry that will look back at the medical records of about 1,000 adults who were treated with the AngioVac system, a device that uses suction to remove blood clots, infected tissue, or other unwanted material from the heart and major blood vessels. The goal is to understand how safe and effective the device is in everyday clinical practice across a wide range of conditions, including heart infections and clots in the heart or lungs. By analyzing outcomes and complications, researchers hope to identify which patients benefit most and to develop best-practice recommendations for its use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AngioVac aspiration system (a device used to suction out unwanted material from blood vessels and heart chambers)
What this could lead to
If successful, this study could provide clearer guidance on when and how to use the AngioVac device, potentially improving outcomes for people with dangerous blood clots or heart infections.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be limited by incomplete data or differences in how centers use the device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOCARDITIS INFECTIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Charité - Universitätsmedizin Berlin, Deutsches Herzzentrum der Charité, Department of Cardiothoracic and Vascular Surgery

    Berlin, 13353, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.